Share on LinkedInShare on LinkedIn

ARTICLE · 17 NOVEMBER 2025

CMA Confirms Evolution In Its Approach To Merger Remedies With New Draft Guidance

Macfarlanes LLP
Macfarlanes LLP
Contributor
Macfarlanes LLP

Macfarlanes LLP

Macfarlanes is a distinctive London-based law firm with a unique combination of services built and...

View firm profile
Explore more from Macfarlanes LLP

Almost a year after it was first announced, the outcome of the CMA's high-profile review of its approach to merger remedies has become clearer with the publication of draft revised...

United KingdomAntitrust/Competition Law

Almost a year after it was first announced, the outcome of the CMA's high-profile review of its approach to merger remedies has become clearer with the publication of draft revised guidance. The revised guidance reflects the CMA's more open-minded approach to complex and/or behavioural remedies, but as we explore in this article, the changes therein are evolutionary rather than revolutionary.

As examined in our previous article, in March this year the CMA launched its keenly awaited review of its approach to merger remedies (the Review). The Review formed part of a CMA programme implementing the "4Ps" – pace, predictability, proportionality and process – across all its work, in the context of increasing pressure from the UK Government on regulators to do more to support economic growth.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from